Lung function, forced expiratory volume in 1 s decline and COPD hospitalizations over 44 years of follow-up

European Respiratory Journal

Volumn 47, Issue 3, 2016, Pages 742-750

  Zaigham, Suneela ^a   Wollmer, Per ^b   Engström, Gunnar ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BREATHING PATTERN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COHORT ANALYSIS; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SPIROMETRY; AGED; KAPLAN MEIER METHOD; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SMOKING; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SWEDEN; TIDAL VOLUME;

AGED; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SPIROMETRY; SWEDEN; TIDAL VOLUME;

EID: 84959908260     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01575-2015     Document Type: Article

References (44)

1. Young RP, Hopkins R, Eaton TE. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 2007; 30: 616-622.
2. Menezes AM, Pérez-Padilla R, Wehrmeister FC, et al. FEV1 is a better predictor of mortality than FVC: the PLATINO cohort study. PLoS One 2014; 9: e109732.
3. Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006; 100: 115-122.
4. Mannino DM, Diaz-Guzman E. Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality. Chest 2012; 141: 73-80.
5. Baughman P, Marott JL, Lange P, et al. Combined effect of lung function level and decline increases morbidity and mortality risks. Eur J Epidemiol 2012; 27: 933-943.
6. Mannino DM, Sonia Buist A, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007; 62: 237-241.
7. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest 2007; 131: 349-355.
8. Van Dijk W, Tan W, Li P, et al. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort. Ann Fam Med 2015; 13: 41-48.
9. Hwang YI, Kim CH, Kang HR, et al. Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria. J Korean Med Sci 2009; 24: 621-626.
10. Runarsdottir SB, Gudmundsson G, Aspelund T, et al Prevalence of airflow obstruction in non-smoking older individuals using different spirometric criteria: the AGES Reykjavik study. COPD 2013; 10: 493-499.
11. Scholes S, Moody A, Mindell JS. Estimating population prevalence of potential airflow obstruction using different spirometric criteria: a pooled cross-sectional analysis of persons aged 40-95 years in England and Wales. BMJ Open 2014; 4: e005685.
12. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
13. Lau AC, Ip MS, Lai CK, et al. Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria. Chest 2008; 133: 42-48.
14. Tilert T, Dillon C, Paulose-Ram R, et al. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre-and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Respir Res 2013; 14: 103.
15. Hnizdo E, Glindmeyer HW, Petsonk EL, et al. Case definitions for chronic obstructive pulmonary disease. COPD 2006; 3: 95-100.
16. Gläser S, Schäper C, Obst A, et al. Impact of different definitions of airflow limitation on the prevalence of chronic obstructive pulmonary disease in the general population. Respiration 2010; 80: 292-300.
17. Vollmer WM, Gíslason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009; 34: 588-597.
18. Mohamed Hoesein FA, Zanen P, Lammers JW. Lower limit of normal or FEV1/FVC <0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011; 105: 907-915.
19. Celli BR, Decramer M, Wedzicha JA, et al. An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 191: e4-e27.
20. Lamprecht B, Schirnhofer L, Kaiser B, et al. Subjects with discordant airways obstruction: lost between spirometric definitions of COPD. Pulm Med 2011; 2011: 780215.
21. Wollmer P, Engström G. Fixed ratio or lower limit of normal as cut-off value for FEV1/VC: an outcome study. Respir Med 2013; 107: 1460-1462.
22. Engström G, Wollmer P, Valind S, et al. Blood pressure increase between 55 and 68 years of age is inversely related to lung function: longitudinal results from the cohort study 'Men born in 1914'. J Hypertens 2001; 19: 1203-1208.
23. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
24. Ford ES, Mannino DM, National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 2004; 27: 2966-2970.
25. Inghammar M, Engström G, Löfdahl CG, et al. Validation of a COPD diagnosis from the Swedish Inpatient Registry. Scand J Public Health 2012; 40: 773-776.
26. Roberts SD, Farber MO, Knox KS, et al. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006; 130: 200-206.
27. Minasian AG, van den Elshout FJ, Dekhuijzen PN, et al. COPD in chronic heart failure: less common than previously thought? Heart Lung 2013; 42: 365-371.
28. Schermer TR, Quanjer PH. COPD screening in primary care: who is sick? Prim Care Respir J 2007; 16: 49-53.
29. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest 2007; 131: 349-355.
30. Miller MR, Quanjer PH, Swanney MP, et al. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest 2011; 139: 52-59.
31. Geijer RM, Sachs AP, Verheij TJ, et al. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up. Br J Gen Pract 2006; 56: 656-661.
32. Bhatt SP, Sieren JC, Dransfield MT, et al. Comparison of spirometric thresholds in diagnosing smoking related airflow obstruction. Thorax 2014; 69: 409-414.
33. Vaz Fragoso CA, Concato J, McAvay G, et al. Chronic obstructive pulmonary disease in older persons: a comparison of two spirometric definitions. Respir Med 2010; 104: 1189-1196.
34. Luoto J, Elmståhl S, Wollmer P, et al. Incidence of airflow limitation in subjects 65-100 years of age. Eur Respir J 2016; 47: 461-472.
35. Drummond MB, Hansel NN, Connett JE, et al. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185: 1301-1306.
36. Akkermans RP, Biermans M, Robberts B, et al. COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers. Eur Respir J 2014; 43: 54-63.
37. Akkermans RP, Berrevoets MA, Smeele IJ, et al. Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects. BMC Pulm Med 2012; 12: 12.
38. Mohamed Hoesein FA, Zanen P, Boezen HM, et al. Lung function decline in male heavy smokers relates to baseline airflow obstruction severity. Chest 2012; 142: 1530-1538.
39. Cerveri I, Corsico AG, Accordini S, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008; 63: 1040-1045.
40. Kalhan R, Arynchyn A, Colangelo LA, et al. Lung function in young adults predicts airflow obstruction 20 years later. Am J Med 2010; 123: 468.e1-7.
41. Mohamed Hoesein FA, Zanen P, Sachs AP, et al. Spirometric thresholds for diagnosing COPD: 0.70 or LLN, pre-or post-dilator values? COPD 2012; 9: 338-343.
42. Güder G, Brenner S, Angermann CE, et al. "GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study". Respir Res 2012; 13: 13.
43. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (updated 2015). www.goldcopd.org/uploads/users/files/GOLD-Report-2015-Sept2.pdf Date last accessed: March 2015. Date last updated: September 2, 2015.
44. Mannino DM, Diaz-Guzman E, Buist S. Pre-and post-bronchodilator lung function as predictors of mortality in the Lung Health Study. Respir Res 2011; 12: 136.